Deutsche Bank AG Purchases 319,709 Shares of Zoetis Inc. $ZTS

Deutsche Bank AG grew its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 5.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,851,737 shares of the company’s stock after purchasing an additional 319,709 shares during the quarter. Deutsche Bank AG owned approximately 1.40% of Zoetis worth $420,506,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Commerzbank Aktiengesellschaft FI increased its holdings in Zoetis by 51.8% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 23,854 shares of the company’s stock valued at $1,714,000 after buying an additional 8,145 shares during the last quarter. Covestor Ltd boosted its stake in shares of Zoetis by 312.9% during the 2nd quarter. Covestor Ltd now owns 2,498 shares of the company’s stock worth $179,000 after acquiring an additional 1,893 shares during the last quarter. Trust Co. of Vermont purchased a new position in shares of Zoetis during the 2nd quarter worth $395,000. Hikari Power Ltd bought a new stake in shares of Zoetis during the 2nd quarter valued at $632,000. Finally, Longfellow Investment Management Co. LLC grew its position in shares of Zoetis by 168.7% during the 2nd quarter. Longfellow Investment Management Co. LLC now owns 10,497 shares of the company’s stock valued at $754,000 after acquiring an additional 6,590 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on ZTS shares. Stifel Nicolaus cut their price target on Zoetis from $95.00 to $85.00 and set a “hold” rating for the company in a report on Friday, June 26th. Piper Sandler decreased their price objective on Zoetis from $90.00 to $80.00 and set a “neutral” rating on the stock in a research note on Monday, August 10th. Citigroup lowered their price objective on Zoetis from $112.00 to $96.00 and set a “buy” rating on the stock in a research report on Tuesday, August 11th. UBS Group cut their price objective on Zoetis from $85.00 to $80.00 and set a “neutral” rating for the company in a research note on Friday, August 7th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Zoetis from $130.00 to $115.00 and set an “overweight” rating for the company in a report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Zoetis has a consensus rating of “Hold” and an average target price of $109.62.

Zoetis Price Performance

Shares of Zoetis stock opened at $72.71 on Tuesday. The stock’s 50-day simple moving average is $76.17 and its 200-day simple moving average is $98.47. Zoetis Inc. has a 52 week low of $71.00 and a 52 week high of $160.48. The company has a market capitalization of $30.05 billion, a price-to-earnings ratio of 11.98, a PEG ratio of 1.28 and a beta of 0.73. The company has a quick ratio of 1.84, a current ratio of 3.08 and a debt-to-equity ratio of 2.87.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.02. Zoetis had a return on equity of 74.89% and a net margin of 27.49%.The firm had revenue of $2.47 billion during the quarter, compared to analyst estimates of $2.50 billion. During the same quarter in the prior year, the company posted $1.76 earnings per share. The business’s quarterly revenue was down .2% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. As a group, analysts expect that Zoetis Inc. will post 6.19 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, July 20th. Zoetis’s dividend payout ratio is presently 34.93%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.